Last update 17 Mar 2026

Mom-PR

Overview

Basic Info

Drug Type
Proteolysis-targeting chimeras (PROTAC)
Synonyms-
Target
ERK1 x FLT3 x IKKα x IKKβ x IRAK1 x JAK2 x PI3Ks
Action
inhibitors, degraders
Mechanism
ERK1 inhibitors(Extracellular-signal-regulated kinase1 inhibitors), FLT3 degraders(Tyrosine-protein kinase receptor FLT3 degraders), IKKα inhibitors(component of inhibitor of nuclear factor kappa B kinase complex inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases+ [1]
Active Indication
Acute Myeloid LeukemiaB-Cell LeukemiaMyelofibrosis
Inactive Indication-
Originator Organization
Cincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical Center
Active Organization
Cincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical Center
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Mom-PR
Login to view more data
100 Translational Medicine associated with Mom-PR
Login to view more data
100 Patents (Medical) associated with Mom-PR
Login to view more data
100 Deals associated with Mom-PR
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPreclinical
United States
Cincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical Center
03 Nov 2025
B-Cell LeukemiaPreclinical
United States
Cincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical Center
03 Nov 2025
MyelofibrosisPreclinical
United States
Cincinnati Children's Hospital Medical CenterCincinnati Children's Hospital Medical Center
03 Nov 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free